FDA Inspection 1082608 — Actimus Biosciences Private Limited

Actimus Biosciences Private Limited — FEI 3006211400

The FDA completed an inspection of Actimus Biosciences Private Limited on Feb 8, 2019 in Visakhapatnam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 8, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Visakhapatnam (India)

Additional Details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.